Bill Type
Congress Name
Long Title
AN ACT EXEMPTING THE SALE AND IMPORTATION OF DRUGS, MEDICINES, PHARMACEUTICAL PRODUCTS AND RELATED RAW MATERIALS, AND PHARMACEUTICAL EQUIPMENT AND INSTRUMENTS USED FOR THE MANUFACTURE THEREOF FROM THE COVERAGE OF REPUBLIC ACT NO. 8424, OTHERWISE KNOWN AS NATIONAL INTERNAL REVENUE CODE OF 1997, AS AMENDED BY REPUBLIC ACT NO. 9337 AND THE IMPOSITION OF TARIFF AND DUTIES AND FOR OTHER PURPOSES
Text as filed (link)
Date filed
July 1, 2013
Scope
Legislative History
House Bill/Resolution NO. HB00131 |
FULL TITLE : AN ACT EXEMPTING THE SALE AND IMPORTATION OF DRUGS, MEDICINES, PHARMACEUTICAL PRODUCTS AND RELATED RAW MATERIALS, AND PHARMACEUTICAL EQUIPMENT AND INSTRUMENTS USED FOR THE MANUFACTURE THEREOF FROM THE COVERAGE OF REPUBLIC ACT NO. 8424, OTHERWISE KNOWN AS NATIONAL INTERNAL REVENUE CODE OF 1997, AS AMENDED BY REPUBLIC ACT NO. 9337 AND THE IMPOSITION OF TARIFF AND DUTIES AND FOR OTHER PURPOSES |
ABSTRACT : Exempts from tariff and duties the importation of drugs, medicines, pharmaceutical products and related raw materials and pharmaceutical instruments used for the manufacture of medicines, provided that such importation is accompanied by a certificate duties issued by the Department of Finance stating that such importation is exempt from tariffs and duties based on a certification by the Food and Drugs Administration that the said products being brought into the country are drugs, medicines, pharmaceutical products and related raw materials and pharmaceutical equipment and instruments used for the manufacture of the same. |
PRINCIPAL AUTHOR/S : VILLAR, MARK A. |
DATE FILED : 2013-07-01 |
SIGNIFICANCE: NATIONAL |
NATURE : Economic |
ACTIONS TAKEN BY THE COMMITTEE ON RULES |
REFERRAL TO THE COMMITTEE ON WAYS AND MEANS ON 2013-07-23 |
Abstract
Exempts from tariff and duties the importation of drugs, medicines, pharmaceutical products and related raw materials and pharmaceutical instruments used for the manufacture of medicines, provided that such importation is accompanied by a certificate duties issued by the Department of Finance stating that such importation is exempt from tariffs and duties based on a certification by the Food and Drugs Administration that the said products being brought into the country are drugs, medicines, pharmaceutical products and related raw materials and pharmaceutical equipment and instruments used for the manufacture of the same.
Disclaimer
Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.